简体中文 | 繁體中文 | English

Products & Services News

2022-01-05 14:35 Alentis Therapeutics Starts First-in-Human Clinical Trial for the Treatment of Liver and Kidney Fibrosis
2022-01-05 11:00 Belkin Named as CES 2022 Innovation Awards Honoree
2022-01-05 10:00 Car Connectivity Consortium Publishes White Paper on the Future of Vehicle Access with Digital Key
2022-01-04 19:32 Enviva Completes Corporate Conversion
2022-01-04 19:11 VEGANZONE Will Grow Vegan Community in 196 Countries!
2022-01-04 14:31 Wemade Launched ‘GalaxyTornado on WEMIX’ On Global Market
2022-01-04 10:18 GIGABYTE Revisits CES and Invites Participants to Explore Industries From a Different Perspective
2022-01-04 10:12 XPeng Announces Vehicle Delivery Results for December and Fourth Quarter 2021
2022-01-04 10:04 Hong Kong New Year Countdown Celebrations Welcome 2022 with the First-Ever Arts Spectacular across Victoria Harbour
2022-01-04 09:54 Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant
2021-12-31 08:58 Delta Air Lines Named as the World’s Best Performing Airline of 2021; All Nippon Airways as the Most On-time Globally
2021-12-30 17:58 Introducing Solidigm – A Market Leader in NAND Flash Technology
2021-12-30 17:52 CHTF 2021 Exhibitions Showcase Leading High-Tech Solutions
2021-12-30 14:42 LEO Pharma Announces FDA Approval of Adbry™ (tralokinumab) as the First and Only Treatment Specifically Targeting IL-13 for Adults With Moderate-to-Severe Atopic Dermatitis
2021-12-30 12:57 World’s Fastest Cross-Chain DeFi Platform Has Launched!
2021-12-30 10:37 Saudi Fund for Development Inaugurates and Lays a Foundation Stone for Two Vital Projects in Sri Lanka
2021-12-29 09:13 TDCX Announces US$188 Million Debt Repayment
2021-12-28 18:02 CHTF 2021 Opens in Shenzhen, China to Promote High Quality Development, Build a New Development Pattern
2021-12-28 10:40 NTT: Realization of Modularized Quantum Light Source Toward Fault-tolerant Large-scale Universal Optical Quantum Computers
2021-12-28 09:20 Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer

Business Wire Weibo

Press Releases

Latest Releases